SCHEMBL4862292

SCHEMBL4862292

CCCCCCCCOc1ccc(-c2ccc(OCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c(F)c2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.38
NR5A1 Q13285 1/20 0.37
PTPN11 Q06124 2/20 0.37
PDK2 Q15119 2/20 0.36
S1PR1 P21453 1/20 0.35
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTR1B P28222 1/20 0.34
HTR2B P41595 1/20 0.34
PLA2G2D Q9UNK4 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4862352 1.00 RARB (0.38) RARBNR5A1PTPN11PDK2S1PR1
SCHEMBL4871834 0.99 RARB (0.39) RARBNR5A1PTPN11PDK2S1PR1
SCHEMBL4870576 0.99 RARB (0.39) RARBNR5A1PTPN11PDK2S1PR1
SCHEMBL4866961 0.94 NR5A1 (0.41) RARBNR5A1PTPN11PDK2TP53
SCHEMBL4870437 0.89 RARB (0.41) RARBS1PR1ALDH1A1CYP3A4
SCHEMBL4871535 0.88 MEN1 (0.46) RARBPTPN11S1PR1ALDH1A1CYP3A4
SCHEMBL4861274 0.87 CNR2 (0.40) RARBNR5A1PTPN11PDK2ALDH1A1
SCHEMBL4867985 0.86 NR5A1 (0.49) RARBNR5A1PTPN11TP53TSHR
SCHEMBL13029250 0.86 NR5A1 (0.49) RARBNR5A1PTPN11TP53TSHR
SCHEMBL9493586 0.86 NR5A1 (0.49) RARBNR5A1PTPN11TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351452-B2 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2008-04-01 US disclosed
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core YBX1, AFF1, AFF2 RARB 1075/4885NR5A1 676/4885PTPN11 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.